P

Inventor

LEDERER EDGAR

FR24 patents
⚠️ This page may combine multiple inventors who share the name “LEDERER EDGAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ANVAR

22 patents
US4235771ANov 25, 1980

Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

ANVAR52 citations94
US4186194AJan 29, 1980

Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

ANVAR36 citations94
US4153684AMay 8, 1979

Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives

ANVAR35 citations92
US4036953AJul 19, 1977

Process for preparing vaccine adjuvant

ANVAR39 citations92
US4185089AJan 22, 1980

Immunological adjuvant constituted by the p-amino-phenyl derivative of N-acetyl-muramyl-L-alanyl-D-isoglutamine

ANVAR46 citations89
US4152423AMay 1, 1979

Immunological agents

ANVAR23 citations81
US3976544AAug 24, 1976

Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction

ANVAR19 citations81
US4220637ASep 2, 1980

Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

ANVAR9 citations74
US4158052AJun 12, 1979

Oil-free adjuvant compositions containing N-acetyl-muramyl-L-alanyl-D-isoglutamine

ANVAR15 citations74
US4125603ANov 14, 1978

Stabilized water-in-oil emulsions and compositions

ANVAR11 citations74
US4693998ASep 15, 1987

Novel compounds of the muramyl peptide

ANVAR9 citations73
US4461761AJul 24, 1984

Oligomers of compounds of the muramyl-peptide type and medicaments containing them

ANVAR10 citations73
US4401659AAug 30, 1983

Muramyl-peptides fixed to peptide-polymers and pharmaceutical compositions containing them

ANVAR8 citations73
US4396607AAug 2, 1983

Muramyl peptide derivatives and pharmaceutical compositions

ANVAR16 citations73
US4370265AJan 25, 1983

Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

ANVAR13 citations72
US4427659AJan 24, 1984

Muramyl peptide substituted on a peptide nitrogen and medicaments containing the same

ANVAR14 citations71
US4272524AJun 9, 1981

N-Acyl-muramyl peptide derivatives having anti-infectious infections properties

ANVAR7 citations71
US4101649AJul 18, 1978

Hydrosoluble agents having non specific immunodepressive properties

ANVAR10 citations68
US4042678AAug 16, 1977

Water-soluble agents having mitogenic properties obtained from nocardia cells, and processes for the preparation thereof

ANVAR9 citations66
US4335111AJun 15, 1982

Compounds associating peptidyl of aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds

ANVAR6 citations63
US4172125AOct 23, 1979

Oil-free adjuvant compositions containing N-acetyl-muramyl-L-alanyl-D-glutamic acid and method of use

ANVAR5 citations63
US4201768AMay 6, 1980

Process for obtaining agents having mitogenic and/or adjuvant properties from Nocardia cells and compositions containing such agents

ANVAR3 citations58

FIRMENICH & CIE

1 patent

HARVARD COLLEGE

1 patent